Peer-reviewed veterinary case report
Blood tests for inflammation in dogs with sudden pancreatitis
By Kim, Hakhyun et al.·Published in The veterinary quarterly·2019·Veterinary Medical Center and College of Veterinary Medicine, South Korea·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Evaluation of serum C-reactive protein and high mobility group box 1 concentrations in 22 dogs with acute pancreatitis: a pilot study.
- Species:
- dog
Plain-English summary
A group of 22 dogs with acute pancreatitis (AP) were studied to understand the levels of certain proteins in their blood. These dogs had higher levels of C-reactive protein (CRP) and high mobility group box 1 (HMGB1) compared to healthy dogs, indicating inflammation. After treatment, the CRP levels decreased, but HMGB1 levels increased, which could help vets assess the severity of the condition. All the dogs showed improvement during their hospital stay, which lasted about six days. This research suggests that HMGB1 might be a helpful marker for monitoring the progression of pancreatitis in dogs.
People also search for: dog pancreatitis symptoms · dog treatment for pancreatitis · high mobility group box 1 in dogs
Abstract
High mobility group box 1 (HMGB1) is an important mediator of systemic inflammatory response syndrome (SIRS) in humans with severe acute pancreatitis (AP), but there is little information regarding its role in dogs.To compare the serum concentrations of C-reactive protein (CRP) and HMGB1 in healthy dogs and those with AP with or without SIRS.The study included 22 dogs with AP and 20 healthy dogs. CRP and HMGB1 were assessed by ELISA. Statistical analyses were conducted by non-parametric tests.Median (interquartile range) serum CRP and HMGB1 concentrations were significantly ( < 0.05) higher in dogs with AP [60.56 (14.50-140.10) µg/mL and 0.35 (0.03-1.12) ng/mL, respectively] than in healthy dogs [2.23 (1.75-5.14) µg/mL and 0.02 (0.01-0.05) ng/mL, respectively]. After the recommended treatments for AP, serum CRP concentration in AP dogs significantly decreased, but that of HMGB1 in AP dogs significantly increased. There was also a significant difference in median serum HMGB1 concentration between AP dogs with and without SIRS. The use of serum HMGB1 concentration of 0.35 ng/mL to distinguish AP dogs with and without SIRS was associated with a sensitivity of 87.5% and a specificity of 71.5%. A positive correlation was identified between HMGB1 and clinical severity of AP. All AP dogs had a positive outcome during hospitalization [6.0 (1.5-6.0) days].Results indicate that HMGB1 might be a useful biomarker for the progression of AP and may play a role in progression of AP into SIRS in dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/31401946/